PhoenixBio Co., Ltd. (TYO:6190)
Japan · Delayed Price · Currency is JPY 344.00
+1.00 (0.29%)
Aug 6, 2026, 2:18 PM JST
PhoenixBio Market Cap
PhoenixBio has a market cap or net worth of 1.4 billion as of August 5, 2026. Its market cap has decreased by -24.74% in one year.
Market Cap
1.40B
Enterprise Value
733.08M
Revenue
1.57B
Ranking
n/a
PE Ratio
11.15
Stock Price
344.00
ChartMarket Cap Chart
Since March 18, 2016, PhoenixBio's market cap has decreased from 8.06B to 1.40B, a decrease of -82.67%. That is a compound annual growth rate of -15.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 1.40B | -29.13% |
| Dec 30, 2025 | 1.97B | 47.38% |
| Dec 30, 2024 | 1.34B | -23.59% |
| Dec 29, 2023 | 1.75B | -25.42% |
| Dec 30, 2022 | 2.35B | 39.61% |
| Dec 30, 2021 | 1.68B | -13.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cyfuse Biomedical K.K. | 5.16B |
| Kohjin Bio | 4.63B |
| D. Western Therapeutics Institute | 4.54B |
| TMS Co., Ltd. | 4.51B |
| Ribomic | 4.13B |
| Transgenic Group | 3.51B |
| Human Metabolome Technologies | 3.29B |
| Modalis Therapeutics | 3.02B |